Abstract:AI is expected to help identify excellent candidates in drug discovery. However, we face a lack of data as it is time consuming and expensive to acquire raw data perfectly for many compounds. Hence, we tried to develop a novel QSAR method to predict a parameter more precisely from an incomplete dataset via optimizing data handling by making use of predicted explanatory variables. As a case study we focused on the tissue-to-plasma partition coefficient (Kp), which is an important parameter for understanding drug distribution in tissues and building the physiologically based pharmacokinetic (PBPK) model, is a representative of small and sparse datasets. In this study, we predicted the Kp values of 119 compounds in nine tissues (adipose, brain, gut, heart, kidney, liver, lung, muscle, and skin), while some of these were not available. To fill the missing values in Kp for each tissue, firstly we predicted those Kp values by the non-missing dataset using a random forest (RF) model with in vitro parameters (log P, fu, Drug Class, and fi) like a classical prediction by a QSAR model. Next, to predict the tissue-specific Kp values in a test dataset, we constructed a second RF model with not only in vitro parameters but also the Kp values of other tissues (i.e. other than target tissues) predicted by the first RF model as explanatory variables. Furthermore, we tested all possible combinations of explanatory variables and selected the model with the highest predictability from the test dataset as the final model. The evaluation of Kp prediction accuracy based on the root-mean-square error and R2-value revealed that the proposed models outperformed other machine learning methods, such as the conventional RF and message-passing neural networks. Significant improvements were observed in the Kp values of adipose tissue, brain, kidney, liver, and skin. These improvements indicated that the Kp information of other tissues can be used to predict the same for a specific tissue. Additionally, we found a novel relationship between each tissue by evaluating all combinations of explanatory variables. In conclusion, we developed a novel RF model to predict Kp values. We hope that this method will be applied to various problems in the field of experimental biology which often contains missing values in the near future.

Artificial intelligence for skin permeability prediction: deep learning

Predictive modeling of skin permeability for molecules: Investigating FDA-approved drug permeability with various AI algorithms

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

PREDICTING SKIN PERMEABILITY OF DRUGS WITH THEORETICAL PARAMETERS

Prediction of Drug Permeation Through Microneedled Skin by Machine Learning

In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals

Natural‐Language Processing (NLP) based feature extraction technique in Deep‐Learning model to predict the Blood‐Brain‐Barrier permeability of molecules

Prediction of Human Skin Permeability Using Artificial Neural Network (ANN) Modeling.

Recent advances in predicting skin permeability of hydrophilic solutes.

Multitask learning for predicting pulmonary absorption of chemicals

In Silico Prediction of Blood-Brain Barrier Permeability of Chemical Compounds through Molecular Feature Modeling

Recent advances in computational prediction of drug absorption and permeability in drug discovery.

The Application of Machine Learning to the Modelling of Percutaneous Absorption: an Overview and Guide

An evaluation of mathematical models for predicting skin permeability.

The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools

Modeling Transdermal Permeation. Part I. Predicting Skin Permeability of Both Hydrophobic and Hydrophilic Solutes

Advances in Computational Approaches for Estimating Passive Permeability in Drug Discovery

Development of Novel Methods for QSAR Modeling by Machine Learning Repeatedly: A Case Study on Drug Distribution to Each Tissue

Artificial Intelligence in Drug Metabolism and Excretion Prediction: Recent Advances, Challenges, and Future Perspectives

Artificial intelligence-powered electronic skin

Predicting Pharmacokinetics of Drugs Using Artificial Intelligence Tools: A Systematic Review